Mumbai, November 14 (IANS). Mahima Chaudhary, the beautiful actress from the film industry and cancer survivor, participated in Pioneering the Future of Healthcare and Diagnostics using 4D Omics organized at IIT Bombay, where she inaugurated 4D Omics Innovations.
The program was organized by Proteomics Lab, Department of Biosciences and Bioengineering. It presented new developments in 4D-proteomics and 4D omics. These areas are poised to revolutionize diagnostics and personalized healthcare. Actress Mahima Chaudhary attended the event as a special guest.
Mahima said that being a breast cancer survivor herself, she has a deep connection with diagnostics. Mahima said, “Cancer is a topic very close to my heart and I am proud to inaugurate this powerful technology here. The use of the 4D Omics platform in cancer diagnostics is a ray of hope for the countless people who are suffering from cancer. Lives are affected by this disease.”
Program coordinator and proteomics expert Professor Sanjeev Srivastava said, “The importance of 4D omics technology in healthcare and diagnostics is important, especially for cancer and chronic diseases. 4D omics adds a time-based dimension to research. It combines genomics, proteomics, transcriptomics and metabolomics with analysis. This shows how much the disease has progressed and what the effect of the therapy will be. “Indeed, the launch of the 4D-proteomics setup is an important step towards improving health.”
Along with this, actress Mahima Chaudhary expressed her gratitude towards IIT Bombay and the scientists involved in this initiative and appreciated them. He said, “I feel proud that such important innovations are happening at IIT Bombay. I am confident that this technology will be a game changer not only for cancer patients, but for everyone. For more information visit 4D You can visit the official website of Omics.
Mahima Chaudhary was also present at the conference along with one of the chief guests, Dr Balram Bhargava, former Director General, ICMR and Dr Judith Stein of Harvard Medical School. Emphasizing the possibilities of 4D omics technology, Dr. Bhargava said, “Integration of multi-dimensional omics data opens new avenues of personalized medicine. It will play an important role in revolutionizing cancer diagnostics and maternal and child healthcare.”
In fact it will be able to give new dimensions to healthcare diagnostics in India. Apart from cancer diagnostics, the event also addressed the role of 4D omics in maternal and child health and its role in preventive wellness. This approach will provide insight into disease mechanisms, progression, and therapeutic response by tracking molecular changes over time.
–IANS
MT/CBT
